Crystal engineering of isostructural quaternary multicomponent crystal forms of olanzapine

Crystal Growth and Design

Volumn 12, Issue 8, 2012, Pages 4194-4201

  Clarke, Heather D ^a   Hickey, Magali B ^b   Moulton, Brian ^a   Perman, Jason A ^a   Peterson, Matthew L ^c   Wojtas, Łukasz ^a   Almarsson, Örn ^b   Zaworotko, Michael J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b ALKERMES INC   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSYCHOTIC DRUG; CO-CRYSTALS; COMPREHENSIVE ANALYSIS; CONFORMATIONAL FLEXIBILITY; CRYSTAL FORMS; CRYSTAL PACKINGS; ENGINEERING DESIGN; ISOSTRUCTURAL; LARGE SCALE PREPARATION; MOLECULAR COMPONENTS; MULTICOMPONENTS; QUATERNARY STRUCTURE; STOICHIOMETRIC RATIO; SUPRAMOLECULAR SYNTHONS; ZYPREXA;

CRYSTAL ENGINEERING; DESIGN; FUNCTIONAL GROUPS; HYDRATES;

DRUG PRODUCTS;

EID: 84864747577     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg3007052     Document Type: Article

References (79)

1. Desiraju, G. R. Crystal Engineering: The Design of Organic Solids; Elsevier: Amsterdam, 1989.
2. Moulton, B.; Zaworotko, M. J. Chem. Rev. 2001, 101, 1629-1658
3. Allen, L. V.; Popovich, N. G.; Ansel, H. C. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems; Lippincott Williams and Wilkins: Baltimore, MD, 2005.
4. Almarsson, Ö.; Zaworotko, M. J. Chem. Commun. 2004, 1889-1896
5. Hickey, M. B.; Almarsson; Peterson, M. L. CrystEngComm 2012, 14, 2349-2349
6. Bernstein, J. Polymorphism in Molecular Crystals; Clarendon Press: Oxford, 2002.
7. Hilfiker, R. Polymorphism: in the Pharmaceutical Industry; Wiley VCH: New York, 2006.
8. Morris, K. In Structural Aspects of Hydrates and Solvates; Brittain, H. G., Ed.; Marcel Dekker: New York, 1999; Polymorphism in Pharmaceutical Solids, Vol. I, pp 125-226.
9. Vippagunta, S. R.; Brittain, H. G.; Grant, D. J. W. Adv. Drug Delivery Rev. 2001, 48, 3
10. Khankari, R. K.; Grant, D. J. Thermochim. Acta 1995, 248, 61-79
11. Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. J. Pharm. Sci. 2006, 95, 499-516
12. Aitipamula, S.; Banerjee, R.; Bansal, A. K.; Biradha, K.; Cheney, M. L.; Choudhury, A. R.; Desiraju, G. R.; Dikundwar, A. G.; Dubey, R.; Duggirala, N.; Ghogale, P. P.; Ghosh, S.; Goswami, P. K.; Goud, N. J.; Jetti, R. K. R.; Karpinski, P.; Kaushik, P.; Kumar, D.; Kumar, V.; Moulton, B.; Mukherjee, A.; Mukherjee, G.; Myerson, A. S.; Puri, V.; Ramanan, A.; Rajamannar, T.; Reddy, C. M.; Rodriguez-Hornedo, N.; Rogers, R. D.; Guru Row, T. N.; Sanphui, P.; Shan, N.; Shete, G.; Singh, A.; Sun, C. C.; Swift, J. A.; Thaimattam, R.; Thakur, T. S.; Thaper, R. K.; Thomas, S. P.; Tothadi, S.; Vangala, V. R.; Variankaval, N.; Vishweshwar, P.; Weyna, D. R.; Zaworotko, M. J. Cryst. Growth Des. 2012, 12, 2147-2152
13. Schultheiss, N; Newman, A. Cryst. Growth Des. 2009, 9, 2950-2967
14. Shan, N.; Zaworotko, M. J. Drug Discovery Today 2008, 13, 440
15. Peterson, M. L.; Collier, E. A.; Hickey, M. B.; Guzman, H.; Almarsson, Ö. Multi-Component Pharmaceutical Crystalline Phases: Engineering for Performance. In Organic Crystal Engineering: Frontiers in Crystal Engineering; Tiekink, E. R.T.; Vittal, J. J.; Zaworotko, M. J., Eds.; John Wiley Publishers: New York, 2010.
16. Jagadeesh Babu, N.; Nangia, A. Cryst. Growth Des. 2011, 11, 2662
17. Cheney, M. L.; Shan, N.; Healey, E. R.; Hanna, M.; Wojtas, Å .; Zaworotko, M. J.; Sava, V.; Song, S.; Sanchez-Ramos, J. R. Cryst. Growth Des. 2010, 10, 394
18. Good, D.; Rodriguez-Hornedo, N. Cryst. Growth Des. 2009, 9, 2252
19. Childs, S. L.; Chyall, L. J.; Dunlap, J. T.; Smolenskaya, V. N.; Stahly, B. C.; Stahly, G. P. J. Am. Chem. Soc. 2004, 126, 13335-13342
20. Remenar, J. F.; Morissette, S. L.; Peterson, M. L.; Moulton, B.; MacPhee, J. M.; Guzman, H. R.; Almarsson, Ö. J. Am. Chem. Soc. 2003, 125, 8456-8457
21. Stanton, M. K.; Bak, A. Cryst. Growth Des. 2008, 8, 3856
22. Trask, A. V.; Motherwell, W. D. S.; Jones, W. Cryst. Growth Des. 2005, 3, 1013-1021
23. Frišcic, T.; Jones, W. J. Pharm. Pharmacol. 2010, 62, 1547-1559
24. Bučar, D.; MacGillivray, L. R. J. Am. Chem. Soc. 2007, 129, 32-33
25. Sander, J. R. G.; Bučar, D.; Henry, R. F.; Zhang, G. G. Z.; MacGillivray, L. R. Angew. Chem., Int. Ed. 2010, 49, 7284-7288
26. Chen, A. M.; Ellison, M. E.; Peresypkin, A.; Wenslow, R. M.; Variankaval, N.; Savarin, C. G.; Natishan, T. K.; Mathre, D. J.; Dormer, P. G.; Euler, D. H.; Ball, R. G.; Ye, Z.; Wang, Y.; Santos, I. Chem. Commun. 2007, 419-421
27. Almarsson, Ö.; Peterson, M. L.; Zaworotko, M. J. Pharm. Patent Analyst 2012, in press.
28. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM281764.pdf.
29. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drug Delivery Rev. 2001, 46, 3-26
30. Chessari, G.; Woodhead, A. J. Drug Discovery Today 2009, 14, 668-675
31. Bhogala, B. R.; Nangia, A. New J. Chem. 2008, 32, 800-807
32. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. Pharm. Res. 1995, 12, 413-420
33. Bymaster, F. P.; Calligaro, D. O.; Falcone, J. F.; Marsh, R. D.; Moore, N. A.; Tye, N. C.; Seeman, P.; Wong, D. T. Neuropsychopharmacology 1996, 14, 87-96
34. Tollefson, G. D.; Beasley, C. M., Jr.; Tran, P. V.; Street, J. S.; Krueger, J. A.; Tamura, R. N.; Graffeo, K. A.; Thieme, M. E. Am. J. Psychiatry 1997, 154 (4) 457-465
35. Smith, R. C.; Infante, M.; Singh, A.; Khandat, A. Int. J. Neuropsychopharmacol. 2001, 4, 239-50
36. Chakrabarti, J. K.; Hotten, T. M.; Tupper, D. E. U.S. Patent 5,229,382, 1993.
37. Bunnell, C. A.; Hendriksen, B. A.; Larsen, S. D. U.S. Patent 5,736,541, 1998.
38. Hamied, Y. K.; Kankan, R. N.; Rao, D. R. U.S. Patent No. 6,348,458, 2002.
39. Reddy, R. B.; Ramesh, C. Patent WO 03/091260, 2003.
40. Thakuria, R.; Nangia, A. Acta Crystallogr. 2011, C67, o461
41. Bunnell, C. A.; Larsen, S. D.; Nichols, J. R.; Reutzel, S. M.; Stephenson, G. A. Patent EP 0831098, Eli Lilly and Co., Indianapolis, IN, 1997.
42. Bunnell, C. A.; Hotten, T. M.; Larsen, S. D.; Tupper, D. E. U.S. Patent 5,631,250, 1995.
43. Hickey, M. B.; Remenar, J. U.S. Patent 2006/0223794, 2006.
44. Wawrzycka-Gorozyca, I. Acta Crystallogr. 2004, E60, o69
45. Wawrzycka-Gorczyca, I.; Borowski, P.; Osypiuk-Tomasik, J.; Mazur, L.; Koziol, A. E. J. Mol. Struct. 2007, 830, 188-197
46. Polla, G. I.; Vega, D. R.; Lanza, H.; Tombari, D. G.; Baggio, R.; Ayala, A. P.; Filho, J. M.; Fernández, D.; Leyva, G.; Dartayet, G. Int. J. Pharm. 2005, 301, 33
47. Capuano, B.; Crosby, I. T.; Fallon, G. D.; Lloyd, E. J.; Turiev, E.; Egan, E. J. Acta Crystallogr. 2003, E59, o1367
48. Gray, J.; Ellend, S. A. Patent WO2004/113346, 2004
49. Sridhar, B.; Ravikumar, K. Zh. Strukt. Khim. 2007, 48, 198-202
50. Ravikumar, K.; Swamy, G. Y. S. K.; Shridhar, B.; Roopa, S. Acta Crystallogr. 2005, E61, 2720
51. Reutzel-Edens, S. M.; Bush, J. K.; Magee, P. A.; Stephenson, G. A.; Byrn, S. R. Cryst. Growth Des 2003, 3, 897-907
52. Thakuria, R.; Nangia, A. CrystEngComm 2011, 13, 1759-1764
53. http://reference.iucr.org/dictionary/Isostructural-crystals.
54. Kalman, A.; Parkanyi, L; Aragay, G. Acta Crystallogr. 1993, B49, 1039-1049
55. Ebenezer, S.; Thomas Muthiah, P.; Butcher, R. J. Cryst. Growth Des. 2011, 11, 3579-3592
56. Cinčić, D.; Frišcić, T.; Jones, W. Chem. - Eur. J. 2008, 14, 747-753
57. Cinčić, D.; Frišcić, T.; Jones, W. New J. Chem. 2008, 32, 1776-1781
58. Cinčić, D.; Frišcić, T.; Jones, W. Chem. Mater. 2008, 20, 6623-6626
59. Dabros, M.; Emery, P. R.; Thalladi, V. R. Angew. Chem., Int. Ed. 2007, 46, 4132
60. Smolka, T.; Boese, R.; Sustmann, R. Struct. Chem. 1999, 10, 429
61. Babu, N. J.; Nangia, A. Cryst. Growth Des. 2006, 6, 1753
62. Edwards, M. R.; Jones, W.; Motherwell, W. D. S. Crys EngComm. 2006, 8, 545
63. Edwards, M. R.; Jones, W.; Motherwell, W. D. S.; Shields, G. P. Mol. Cryst. Liq. Cryst. 2001, 356, 337-353
64. Wood, P. A.; Oliveira, M. A.; Zink, A.; Hickey, M. B. CrystEngComm 2012, 14, 2413-2421
65. Ong, W.; Cheung, E. Y.; Schultz, K. A.; Smith, C.; Bourassa, J.; Hickey, M. B. CrystEngComm 2012, 14, 2428-2434
66. Clarke, H. D.; Arora, K. K.; Bass, H.; Kavuru, P.; Ong, T.; Pujari, T.; Wojtas, Å .; Zaworotko, M. J. Cryst. Growth Des. 2010, 10, 2152
67. Clarke, H. D.; Arora, K. K.; Wojtas, Å .; Zaworotko, M. J. Cryst. Growth Des. 2011, 11, 964
68. Galcera, J.; Molins, E. Cryst. Growth Des. 2009, 9, 327-334
69. Bruker (APEX2); Bruker AXS Inc.: Madison, Wisconsin, USA, 2010.
70. Bruker SAINT, Data Reduction Software; Bruker AXS Inc., Madison, Wisconsin, USA, 2009.
71. Sheldrick, G. M. SADABS. Program for Empirical Absorption Correction; University of Gottingen, Germany, 2008.
72. Farrugia, L. J. Appl. Crystallogr. 1999, 32, 837-838
73. Sheldrick, G. M. SHELXL-97, 1997.
74. Sheldrick, G. M. Acta Crystallogr. 1990, A46, 467-473
75. Sheldrick, G. M. Acta Crystallogr. 2008, A64, 112-122
76. Petcher, T. J.; Weber, H.-P. J. Chem. Soc., Perkin Trans. 2 1976, 1415-1420
77. Saha, B. K.; Nangia, A. Heteroat. Chem. 2007, 18, 185
78. Desiraju, G. R. Science 1997, 278, 404
79. Desiraju, G. R. Nat. Mater. 2002, 1, 77